Systemic Lupus Erythematosus, considered a collection of diseases, is an autoimmune disorder in which the immune system attacks healthy tissues, especially in the joints (including fingers, wrists, hands, and knees).

auto immune header1

 

Lupus

Patients often develop fatigue, rash, and swollen lymph nodes, but many organs can be affected. As with other autoimmune conditions, anti-inflammatory medications and immune-suppressants are used commonly for treatment. Sometimes cytotoxic drugs are used for severe cases. Research is also ongoing to evaluate the effects of stem cells on autoimmune conditions.

lymph nodeLupus and Cell Surgical Network has developed a specific SVF deployment protocol that attempts to utilize the immuno-regulatory and anti-inflammatory properties of SVF (rich in mesenchymal stem cells and growth factors) to mitigate the effects of Lupus. SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Lupus Call  to Action We care about our Lupus patients at Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out a Confidential Candidate Application, we will answer the questions and concerns you may have about Cell Surgical Network protocols for Lupus.

Relapsing Polychondritis

Relapsing Polychondritis is an autoimmune condition characterized by the body attacking its own cartilage. Polychondritis patients suffer from recurrent relapsing episodes of painful cartilage inflammation. Susceptible areas include ears, nasopharynx, heart valves, and blood vessels.  As stated in the Annals of Internal Medicine, the disease is life threatening and debilitating. There is no one specific test for identifying Polychondritis and the course of the disease is often unpredictable. Treatment consists of anti-inflammatory medications and immune suppression with corticosteroids. Research is ongoing to evaluate the effects of stem cells on autoimmune conditions. According to the Journal of Rheumatology Supplements, “the opportunity to ablate (with autologous stem cells) severe autoimmune disease with increased safety is particularly attractive for necrotizing vasculitides, polymyositis/dermatomyositis, primary Sjögren’s syndrome, systemic juvenile arthritis, and relapsing Polychondritis.”

heart valveRelapsing Polychondritis and Cell Surgical Network CELL SURGICAL NETWORK has developed a specific SVF deployment protocol for Polychondritis that attempts to utilize the potential immune-modulatory, anti-inflammatory, and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Relapsing Polychondritis Call to Action We care about our Relapsing Polychondritis patients at Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out the Confidential Candidate Application, we will answer the questions and concerns you may have about Cell Surgical Network protocols for Relapsing Polychondritis.

Autoimmune Hepatitis

Auto-immune hepatitis is an inflammatory autoimmune disease of the liver. It often occurs with other autoimmune conditions such as Scleroderma, Lupus, Crohn’s, and Graves Thyroid disease. Patients experience fatigue, loss of appetite, itching, and abdominal distension. Treatment with corticosteroids is the standard of care, but the hepatitis may cause cirrhosis (scarring) and eventually lead to liver failure. A new study from Germany indicates that it is important to establish the diagnosis before cirrhosis develops. Read more…  Research is ongoing to evaluate the effects of stem cells on autoimmune conditions.

Autoimmune Hepatitis and Cell Surgical Network CELL SURGICAL NETWORK has developed a specific SVF deployment protocol for hepatitis that attempts to utilize the potential immune-modulatory, anti-inflammatory, and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Autoimmune Hepatitis Call to Action We care about our Autoimmune Hepatitis patients at Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out Confidential Candidate Application, we will answer all of the questions and concerns you may have about Cell Surgical Network protocols for Auto-immune Hepatitis. Our Cell Surgical Network has Treatment Centers in several states. Locate the closest treatment center in our Physician Network on Our Physician Network Map.

Crohn's Disease

Crohn’s disease is a type of inflammatory bowel disease that occurs in half a million people in North America. It may affect any part of the gastrointestinal tract from mouth to anus, causing a wide variety of symptoms, includingabdominal pain, bloating, diarrhea (which may be bloody if inflammation is at its worst), vomiting (can be continuous), or weight loss. Skin rashes andarthritis can also occur. Crohn’s disease has a genetic component, but it is an autoimmune disease in which the person’s own immune system attacks the gastrointestinal tract possibly directed at microbial antigens. The terminal ileum is the part of the bowel most often affected in this disease. Treatment often includes immune-suppressant therapy with steroids. Antibiotics and anti-inflammatories are also used extensively. In Europe, stem cells are used commonly to treat Crohn’s. Research is ongoing to evaluate the effects of stem cells on autoimmune conditions. The Journal of Translational Research reports that “non-expanded SVF cells have been used successfully in accelerating healing of Crohn’s fistulas”

Crohn’s Disease and Cell Surgical Network has developed a specific SVF deployment protocol that attempts to utilize the potential immune-modulatory, anti-inflammatory, and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Crohn’s Disease Call to Action We care about our Crohn’s patients at Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out our Confidential Candidate Application, we will answer all of the questions and concerns you may have about Cell Surgical Network protocols for Crohn’s disease. Our Cell Surgical Network has Treatment Centers in several states. Locate the closest treatment center in our Physician Network using Our Physician Network Map.

Rheumatoid Arthritis

Rheumatoid arthritis is an autoimmune disease common in middle age, especially in women. The disease affects peripheral joints, including the wrists, feet, ankles, and knees. The cause is unknown and eyes and skin also can be involved. Early aggressive therapy with immunosuppressive drugs and anti-inflammatories appears to delay joint destruction. More recently, biologic agents have been added to regimens that include TNF inhibitors, WBC modulators, and growth factor inhibitors. Research is ongoing to evaluate the effects of stem cells on autoimmune conditions. According to the Journal of Translational Research, “The ability of MSC to inhibit immune response, while offering the possibility of inducing/accelerating healing of tissue that has already been damaged, makes this population attractive for treatment of autoimmune disorders.”

Rheumatoid Arthritis and Cell Surgical Network CELL SURGICAL NETWORK has developed a specific SVF deployment protocol that attempts to utilize the potential immune-modulatory, anti-inflammatory, and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Rheumatoid Arthritis Call to Action We care about our Rheumatoid Arthritis patients at Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out Confidential Candidate Application, we will answer the questions and concerns you may have about Cell Surgical Network protocols for Rheumatoid Arthritis. Our Cell Surgical Network has Treatment Centers in several states. Locate the closest treatment center on Our Physician Network Map.

Myasthenia Gravis

Myasthenia Gravis (MG) is an autoimmune neuromuscular disease leading to fluctuating muscle weakness and fatigability. It is an autoimmune disorder, in which weakness is caused by circulating antibodies that inhibit the excitatory effects of the neurotransmitter acetylcholine on neuromuscular junctions. Muscular fatigue is often seen and MG is associated with ocular problems, and speech, swallowing, and breathing can be affected. Myasthenia Gravis is treated medically with acetylcholinesterase inhibitors or immunosuppressants, and in select cases, thymectomy. MG is associated with other autoimmune conditions, including thyroid disease, lupus, and diabetes. Animal model studies are ongoing and, according to the Scandinavian Journal of Immunology in 2010, a study demonstrated that hMSC (mesenchymal stem cells) treatment was therapeutically useful in autoimmune myasthenia gravis mice, and the underlying mechanism may relate to their immunomodulatory potential. Human research is ongoing to evaluate the effects of stem cells on autoimmune conditions. Myasthenia Gravis and Cell Surgical Network CELL SURGICAL NETWORK has developed a specific SVF deployment protocol that attempts to utilize the potential immune-modulatory and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors) to mitigate symptoms of Myasthenia Gravis. SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Myasthenia Gravis Call to Action

We care about our Myasthenia Gravis patients at the Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out Confidential Candidate Application, we will answer the questions and concerns you may have about Cell Surgical Network protocols for Myasthenia Gravis. Our Cell Surgical Network has Treatment Centers in several states. Locate the closest treatment center on Our Physician Network Map.

“I can now do what I really love, move cattle on horseback all day long, without depending on daily pain medication.  I am amazed at my recovery and would recommend this procedure to all who suffer as I did.”

David Cross

Past President/Kansas Livestock Association

Follow Us

Visit Us On FacebookVisit Us On YoutubeVisit Us On LinkedinVisit Us On TwitterVisit Us On GooglePlus

Join us for our next webinar!

Select a date that works for you!
CLICK FOR DETAILS >>

Stem Cells and the FDA

Stem cell treatment is not approved by the FDA for any specific disease.
CLICK FOR DETAILS >>

Blog Posts